NeuroMag™ Magnesium L-Threonate
Recover
Form
Purity
Target
The Brain Magnesium Problem
The Brain Magnesium Problem
Why Brain Magnesium Deficiency Is Epidemic
Magnesium deficiency is remarkably common — estimated at 50-90% of the population — but brain magnesium deficiency is even more problematic because:Brain Magnesium: The Numbers
| Metric | Value | Significance |
|---|---|---|
| CSF Mg concentration | 1.0-1.2 mM | Tightly regulated by BBB |
| Brain Mg as % of body Mg | ~0.3% | Tiny fraction of total stores |
| Serum-CSF Mg correlation | Weak | Blood Mg ≠ Brain Mg |
| Age-related brain Mg decline | ~20-30% | Correlates with cognitive decline |
| Mg needed for ATP function | Every ATP molecule | Mg-ATP is the active form |
Why the Brain Guards Its Magnesium
The blood-brain barrier (BBB) tightly controls magnesium entry:Why This Matters for Sleep
Brain magnesium is critical for sleep through multiple mechanisms:| Sleep Mechanism | Mg Role | Deficiency Consequence |
|---|---|---|
| GABA-A receptor function | Positive allosteric modulator | ↓ Inhibition, ↑ Anxiety |
| NMDA receptor regulation | Voltage-dependent block | Excitotoxicity, poor memory consolidation |
| Melatonin synthesis | Cofactor for AANAT | ↓ Melatonin production |
| HPA axis regulation | Modulates cortisol | ↑ Night cortisol, ↑ Awakenings |
| Muscle relaxation | Ca²⁺ antagonist | Restlessness, cramps |
| Parasympathetic tone | Vagal nerve function | ↓ HRV, ↑ Sympathetic dominance |
Mechanism of Action
Mechanism of Action
How Magnesium L-Threonate Crosses the Blood-Brain Barrier
The breakthrough of Mg L-Threonate lies in its unique transport mechanism:The L-Threonate Carrier Advantage
| Property | L-Threonate | Standard Mg²⁺ |
|---|---|---|
| BBB permeability | High (uses GLUT transporters) | Low (limited Mg channels) |
| Brain Mg increase | +15-25% (demonstrated) | Minimal (<5%) |
| CSF penetration | Efficient | Poor |
| Mechanism | Hitchhikes on glucose transport | Passive diffusion only |
| Origin | Vitamin C metabolite | N/A |
Unique GLUT Transporter Utilization
L-Threonate’s structure allows it to utilize glucose transporters:Key Insight: L-Threonate has structural features that allow recognition by GLUT transporters — the same highly efficient transporters that deliver glucose to the energy-hungry brain. This “Trojan horse” mechanism bypasses the normal limitations on magnesium BBB penetration.Once in the Brain: Magnesium’s Neural Actions
Mechanism Summary Table
| Receptor/Target | Mg²⁺ Action | Functional Effect |
|---|---|---|
| NMDA Receptor | Voltage-dependent pore block | Reduces excitotoxicity; enhances signal:noise |
| GABA-A Receptor | Positive allosteric modulator | Anxiolysis; sleep promotion |
| BDNF | Upregulates expression | Neuroplasticity; synaptic density |
| Na⁺/K⁺-ATPase | Essential cofactor | Maintains neuronal membrane potential |
| ATP | Forms Mg-ATP complex | All energy-dependent processes |
| Adenylate Cyclase | Cofactor | cAMP signaling |
| Presynaptic Ca²⁺ channels | Modulates | Neurotransmitter release |
Why Standard Magnesium Forms Fail
Why Standard Magnesium Forms Fail
The Bioavailability Illusion
Many magnesium forms have good systemic bioavailability but poor CNS delivery:Head-to-Head Comparison
| Form | Elemental Mg (%) | GI Absorption | Serum ↑ | Brain ↑ | Sleep Evidence |
|---|---|---|---|---|---|
| Mg Oxide | 60% | Poor (4%) | Low | Minimal | Weak |
| Mg Citrate | 16% | Good | Good | Minimal | Limited |
| Mg Glycinate | 14% | Good | Good | Minimal | Moderate (muscle) |
| Mg Malate | 15% | Good | Good | Minimal | Weak |
| Mg Taurate | 9% | Good | Good | Minimal | Weak |
| Mg Chloride | 12% | Good | Good | Minimal | Weak |
| Mg L-Threonate | 7.2% | Good | Moderate | +15-25% | Strong (RCT) |
The Elemental Magnesium Paradox
Mg L-Threonate appears to have less elemental magnesium — but this is misleading:| Comparison | Mg Citrate (500mg) | Mg L-Threonate (2,000mg) |
|---|---|---|
| Elemental Mg | 80mg | 144mg |
| Serum Mg increase | Higher | Lower |
| Brain Mg increase | ~0-5% | ~15-25% |
| Sleep quality RCTs | None specific | Multiple positive |
| Cognitive RCTs | None specific | Multiple positive |
Why Glycinate Isn’t the Answer (For Sleep)
Magnesium glycinate is often recommended for sleep, but the evidence is indirect:Glycinate’s Sleep Effects:- Partially from glycine release (better addressed by dedicated glycine supplementation)
- Partially from peripheral muscle relaxation (real but limited)
- Minimal direct CNS effects (doesn’t cross BBB efficiently)
- Direct brain Mg elevation (proven in animal/human studies)
- Enhanced GABA-A receptor function in brain
- Improved deep sleep architecture (Oura Ring validated)
- Better HRV during sleep (parasympathetic shift)
- Mg L-Threonate in Recover — For direct brain effects (sleep quality, anxiety, cognition)
- Mg Citrate in Luna drink — For peripheral effects (muscle relaxation) + the glycine in Luna provides the amino acid benefits
Clinical Evidence: Sleep
Clinical Evidence: Sleep
Landmark 2024 RCT: Oura Ring Validation
Study: Hausenblas et al., 2024Design: Randomized, double-blind, placebo-controlled
Population: 80 adults (35-55 years) with self-reported sleep difficulties
Intervention: 1g Mg L-Threonate (Magtein®) vs placebo × 21 days
Validation: Oura Ring objective sleep tracking + validated questionnaires
Primary Outcomes
| Measure | Magtein® Change | Placebo Change | Significance |
|---|---|---|---|
| Insomnia Severity Index | ↓ Significant | No change | p < 0.05 |
| Leeds Sleep Evaluation | ↑ Significant | Minimal | p < 0.05 |
| Restorative Sleep Questionnaire | ↑ Significant | No change | p < 0.05 |
Oura Ring Objective Data
| Sleep Metric | Magtein® Effect | Interpretation |
|---|---|---|
| Deep Sleep Duration | ↑ Significant | More restorative N3 sleep |
| REM Sleep Duration | ↑ Significant | Better memory consolidation |
| HRV (During Sleep) | ↑ Significant | Enhanced parasympathetic tone |
| Resting Heart Rate | ↓ Significant | Reduced sympathetic activation |
Timeline of Effects
Additional Sleep Outcomes
| Secondary Measure | Finding |
|---|---|
| Mood upon waking | Improved |
| Daytime energy | Increased |
| Daytime alertness | Enhanced |
| Daily activity/productivity | Improved |
2025 RCT: Extended Cognitive + Sleep Study
Study: Magtein® clinical trial, 2025Design: RCT, 6 weeks
Population: Adults 25-45 years
Outcomes: Cognitive performance + sleep quality
| Outcome Domain | Result |
|---|---|
| Cognitive performance | ↑ Significant improvement |
| Hand-eye coordination | ↑ Significant improvement |
| Reaction time | ↑ Significant improvement |
| PROMIS Sleep measure | ↑ Significant improvement |
| Resting heart rate | ↓ Decreased |
| Sleep HRV | ↑ Increased |
Mechanism Validation: Sleep Architecture
The objective Oura Ring data validates the proposed mechanism:Clinical Evidence: Cognition
Clinical Evidence: Cognition
Foundational Research: MIT Discovery
Magtein® originated from research at MIT by Dr. Guosong Liu’s laboratory:Key Finding (Slutsky et al., 2010, Neuron):- Magnesium L-threonate increases brain magnesium by ~15% in rodents
- Enhanced synaptic plasticity in hippocampus
- Improved short-term and long-term memory
- Increased synapse density in prefrontal cortex and hippocampus
Human Cognitive Trials
Study 1: Liu et al., 2016- Population: Adults 50-70 years with cognitive complaints
- Intervention: Magtein® 1.5-2g/day × 12 weeks
- Outcomes:
- ↑ Executive function (TMT-B)
- ↑ Working memory
- Brain age reversal: ~9 years younger (cognitive testing)
- Population: Adults 25-45 years
- Intervention: Magtein® × 6 weeks
- Outcomes:
- ↑ Cognitive performance
- ↑ Hand-eye coordination
- ↑ Reaction time
Cognitive Outcome Summary
| Cognitive Domain | Evidence | Mechanism |
|---|---|---|
| Working memory | Strong | ↑ Prefrontal Mg; ↑ DLPFC function |
| Executive function | Strong | ↑ Prefrontal synaptic density |
| Learning | Moderate | ↑ Hippocampal LTP |
| Attention | Moderate | ↑ Thalamo-cortical Mg |
| Processing speed | Moderate | ↑ Overall neural efficiency |
Brain Age Reversal Concept
Whole Foods Sources
Whole Foods Sources
Magnesium Content of Common Foods
| Food Source | Serving | Mg (mg) | % DV (420mg) |
|---|---|---|---|
| Pumpkin seeds | 1 oz (28g) | 156 | 37% |
| Chia seeds | 1 oz (28g) | 111 | 26% |
| Almonds | 1 oz (28g) | 80 | 19% |
| Spinach (cooked) | 1 cup | 157 | 37% |
| Cashews | 1 oz (28g) | 74 | 18% |
| Black beans | 1 cup | 120 | 29% |
| Edamame | 1 cup | 100 | 24% |
| Dark chocolate (70%+) | 1 oz (28g) | 65 | 15% |
| Avocado | 1 medium | 58 | 14% |
| Salmon | 3 oz (85g) | 26 | 6% |
| Brown rice | 1 cup cooked | 84 | 20% |
| Banana | 1 medium | 32 | 8% |
The Food-Brain Gap Problem
Even with an excellent diet rich in magnesium, brain magnesium remains limited:Why L-Threonate Isn’t in Food
L-Threonate is a metabolite of vitamin C, not a dietary mineral:| Compound | Natural Source | Dietary Availability |
|---|---|---|
| Magnesium | Seeds, nuts, greens, beans | Abundant |
| L-Threonate | Vitamin C metabolism | Not dietary |
| Mg L-Threonate | Synthetic combination | Supplement only |
Food + Supplement Strategy
For optimal magnesium status:| Strategy | Target | Rationale |
|---|---|---|
| Magnesium-rich diet | ~400-500mg/day | Foundation; whole-body Mg |
| Mg L-Threonate (Recover) | 2,000mg (144mg Mg) | Brain-specific delivery |
| Mg Citrate (Luna) | 100-150mg Mg | Peripheral muscle relaxation |
Signs of Magnesium Deficiency
| Symptom Category | Signs | Brain vs Peripheral |
|---|---|---|
| Muscle | Cramps, twitches, restless legs | Peripheral |
| Energy | Fatigue, weakness | Both |
| Sleep | Difficulty falling/staying asleep | Brain |
| Mood | Anxiety, irritability | Brain |
| Cognitive | Poor concentration, brain fog | Brain |
| Cardiovascular | Irregular heartbeat, palpitations | Both |
Dosing & Form Selection
Dosing & Form Selection
Magtein® Dose Selection
| Clinical Context | Dose | Elemental Mg | Evidence Base |
|---|---|---|---|
| Sleep optimization | 2,000 mg | 144 mg | 2024 RCT (Hausenblas) |
| Cognitive enhancement | 1,500-2,000 mg | 108-144 mg | Liu 2016, MIT research |
| Anxiety support | 1,500-2,000 mg | 108-144 mg | Mechanistic |
| NTRPX Recover dose | 2,000 mg | 144 mg | Clinical dose alignment |
Why 2,000mg (Not Lower)?
Note: The 2024 sleep RCT used 1,000mg, but cognitive trials suggest 1,500-2,000mg for full effect. NTRPX uses 2,000mg to ensure optimal coverage for both sleep and cognitive benefits.Timing Protocol
| Timing | Rationale | Protocol |
|---|---|---|
| Evening (60-90 min before bed) | Peak effect aligns with sleep | Recover capsules |
| Split dosing option | Maintain stable levels | 1,000mg AM + 1,000mg PM |
| With or without food | Absorption not significantly affected | Flexible |
Form Comparison: Magtein® vs Generic
| Parameter | Magtein® (MGC) | Generic MgT |
|---|---|---|
| Manufacturer | Mitsubishi Gas Chemical | Various |
| Research backing | All published studies | None |
| Purity specification | Defined, consistent | Variable |
| Quality assurance | Rigorous | Unknown |
| Patent status | Patented process | May infringe |
| Cost | Premium | Lower |
Capsule Requirements
| Dose Target | Capsule Strategy | Count |
|---|---|---|
| 2,000mg Magtein® | 2 × 1,000mg (size 00) | 2 capsules |
| Split with other ingredients | Varies | 2-3 capsules |
Safety & Classification
Safety & Classification
Adverse Event Profile
| Event | Incidence | Severity | Notes |
|---|---|---|---|
| Headache | Occasional (~5%) | Mild | Usually transient, first week |
| Drowsiness | Occasional | Mild | Expected for sleep product; take PM |
| GI discomfort | Rare (<3%) | Mild | Less than other Mg forms |
| Dizziness | Rare | Mild | Usually with high doses |
Safety Data
| Parameter | Finding |
|---|---|
| Acute toxicity | Very low (Mg is tightly regulated) |
| Chronic safety | Well-tolerated in 12-week trials |
| Genotoxicity | Negative (L-threonate is endogenous) |
| Drug interactions | Minimal (see below) |
| Pregnancy/lactation | Insufficient data; consult provider |
| Pediatric | Not studied; adult formulation |
Regulatory Status
| Region | Status |
|---|---|
| United States | GRAS (Generally Recognized as Safe) |
| FDA | New Dietary Ingredient notification filed |
| European Union | Novel food application pending |
| Canada | Licensed as NHP |
| Australia | Listed medicine eligible |
Drug Interactions
| Drug Class | Interaction | Severity | Management |
|---|---|---|---|
| Bisphosphonates | ↓ Absorption | Moderate | Separate by 2+ hours |
| Antibiotics (quinolones, tetracyclines) | Chelation | Moderate | Separate by 2+ hours |
| Diuretics (loop, thiazide) | ↑ Mg excretion | Low | Monitor Mg status |
| Muscle relaxants | Additive | Low | Usually beneficial |
| CNS depressants | Additive sedation | Low | Monitor; usually fine |
Contraindications
| Condition | Concern | Recommendation |
|---|---|---|
| Severe renal impairment | ↓ Mg excretion | Avoid or consult nephrologist |
| Myasthenia gravis | Mg may worsen weakness | Avoid |
| Heart block | Mg may exacerbate | Consult cardiologist |
| Hypermagnesemia | Additive | Avoid |
Special Populations
| Population | Safety Status | Notes |
|---|---|---|
| Healthy adults | Well-established | Primary study population |
| Elderly (50-70) | Well-established | Cognitive trials in this group |
| Sleep-disturbed | Well-established | 2024 RCT |
| Pregnancy | Insufficient data | Consult provider |
| Lactation | Insufficient data | Consult provider |
| Children | Not studied | Not recommended |
| Renal impairment | Caution | Consult nephrologist |
Tier Classification
Tier 2: Supported
Efficacy
Validation
Safety
Synergies within NTRPX
Synergies within NTRPX
Recover Stack Synergies
Specific Synergy Pairs
| Combination | Mechanism | Expected Benefit |
|---|---|---|
| MgT + L-Theanine | Dual GABA support | Enhanced relaxation without sedation |
| MgT + Magnolia Bark | GABA-A enhancement | Deeper anxiolysis |
| MgT + Ashwagandha | HPA axis + neural Mg | Comprehensive stress buffering |
| MgT + Glycine (Luna) | Different mechanisms (GABA vs thermoregulation) | Complementary sleep onset |
| MgT + Melatonin | Neural preparation + circadian signal | Optimized sleep architecture |
Why Dual Magnesium Strategy (L-Threonate + Citrate)
Cross-Product Integration
| Product | Mg Form | Dose | Rationale |
|---|---|---|---|
| Recover (capsules) | L-Threonate | 2,000mg (144mg Mg) | Brain-specific |
| Luna (drink) | Citrate | 100-150mg Mg | Peripheral muscle |
| Boost | None | — | Morning; Mg not needed |
| Sustain | None | — | Afternoon; Mg not needed |
Circadian Integration
Historical & Biochemical Context
Historical & Biochemical Context
Discovery Timeline
| Year | Milestone |
|---|---|
| 2004 | Dr. Guosong Liu (MIT) begins research on brain magnesium |
| 2010 | Slutsky et al. publish landmark Neuron paper on MgT |
| 2010 | Mitsubishi Gas Chemical licenses Magtein® |
| 2012 | First human cognitive trial initiated |
| 2016 | Liu et al. publish human cognitive trial results |
| 2020 | FDA GRAS notification for Magtein® |
| 2024 | Hausenblas et al. publish Oura Ring sleep validation RCT |
| 2025 | Extended cognitive + sleep trial results |
The MIT Discovery Story
Dr. Guosong Liu, a neuroscientist at MIT’s Picower Institute for Learning and Memory, observed that:- Brain magnesium deficiency correlates with cognitive decline
- Standard magnesium supplements don’t meaningfully raise brain Mg
- A new delivery mechanism was needed
- Its small molecular size
- Structural similarity to glucose (GLUT recognition)
- Endogenous origin (vitamin C metabolite)
- Safety profile
Magnesium L-Threonate Structure
| Property | Value |
|---|---|
| Molecular formula | C₈H₁₄MgO₁₀ |
| Molecular weight | 294.5 g/mol |
| Elemental Mg | 7.2% by weight |
| Solubility | Freely soluble in water |
| pKa | ~3.5 (carboxylic acid) |
| Stability | Stable at room temperature |
L-Threonate: A Vitamin C Metabolite
This endogenous origin contributes to Magtein®‘s excellent safety profile — L-threonate is a compound the body naturally produces and metabolizes.Why Magnesium Is Essential for Neural Function
| Function | Mechanism | Consequence of Deficiency |
|---|---|---|
| ATP binding | Mg-ATP is active form | ↓ Energy availability |
| NMDA regulation | Voltage-dependent block | Excitotoxicity, ↓ learning |
| GABA-A modulation | PAM activity | ↓ Inhibition, ↑ anxiety |
| 300+ enzymes | Cofactor | Widespread metabolic dysfunction |
| DNA/RNA synthesis | Polymerase cofactor | ↓ Cellular repair |
| Protein synthesis | Ribosome function | ↓ Neurotransmitter production |
Practical Considerations
Practical Considerations
When to Use Mg L-Threonate
| Scenario | Expected Benefit | Protocol |
|---|---|---|
| Sleep quality issues | High | 2,000mg, 60-90 min before bed |
| Cognitive optimization | High | 2,000mg daily, 8-12 weeks |
| Anxiety with poor sleep | High | 2,000mg evening |
| Age-related cognitive decline | High | 2,000mg daily, ongoing |
| General Mg supplementation | Moderate | Consider if brain symptoms present |
Realistic Expectations
| Timeframe | What to Expect |
|---|---|
| Day 1-3 | Subtle relaxation; possible mild drowsiness |
| Week 1 | Emerging sleep quality improvement |
| Week 2-3 | Clear sleep benefits; early cognitive effects |
| Week 4-8 | Full sleep + cognitive benefits established |
| Week 12+ | Optimal neuroplasticity effects (cognitive) |
Signs It’s Working
| Indicator | Description |
|---|---|
| Faster sleep onset | Less time lying awake |
| Fewer awakenings | More consolidated sleep |
| More refreshed mornings | Better sleep quality |
| Improved focus | Better sustained attention |
| Reduced anxiety | Calmer baseline state |
| Better memory | Easier recall (over time) |
Administration Tips
| Tip | Rationale |
|---|---|
| Take in evening | Sleep benefits align with bedtime |
| Consistent daily use | Brain Mg elevation is gradual |
| Can take with or without food | Minimal absorption difference |
| Be patient | Full cognitive benefits take 8-12 weeks |
| Combine with Recover stack | Synergistic with other sleep compounds |
Frequently Asked Questions
Why is the elemental magnesium so low compared to other forms?
Why is the elemental magnesium so low compared to other forms?
Can I take Mg L-Threonate with other magnesium supplements?
Can I take Mg L-Threonate with other magnesium supplements?
Why not just take more regular magnesium?
Why not just take more regular magnesium?
Is Magtein® worth the premium over generic Mg L-Threonate?
Is Magtein® worth the premium over generic Mg L-Threonate?
Will Mg L-Threonate help my muscle cramps?
Will Mg L-Threonate help my muscle cramps?
How long do I need to take it?
How long do I need to take it?
Can I take it in the morning instead of evening?
Can I take it in the morning instead of evening?

